Safety, Efficacy, and Pharmacokinetics Study of Tarceva to Treat Advanced Colorectal Cancer

Part of paid clinical trials in Indianapolis, Indiana.

Sponsor
Genentech, Inc.
Study ID
NCT00047762
Phase
PHASE1
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

The purpose of this study is test the safety of Tarceva, find the best dose, and see what effects (good and bad) it has on you and your colorectal cancer. The effects of Tarceva will be evaluated in combination with 5-fluorouracil, leucovorin, and irinotecan, with or without Bevacizumab.

Key Dates

First listed
Oct 18, 2002
Start date
Oct 31, 2002
Status verified
Nov 2004

Study Design

Allocation
RANDOMIZED
Primary purpose
TREATMENT

Locations (3)

FacilityCityStateZIPSite coordinators
Indiana University Cancer PavilionIndianapolisIndiana46202-
Johns Hopkins Oncology CenterBaltimoreMaryland21231-1000-
Mary Crowley Medical Research CenterDallasTexas75246-2006-

Find similar trials in Indianapolis, IN

By condition
Colorectal cancer
By specialty
OncologyGI oncology
By research site
Indiana University Cancer Pavilion· Indianapolis, INJohns Hopkins Oncology Center· Baltimore, MDMary Crowley Medical Research Center· Dallas, TX

Related Studies